We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image: Low magnification micrograph of mantle cell lymphoma of the terminal ileum (Image Credit: Nephron/Wikimedia Commons, CC BY-SA 3.0)

Biomarker-Guided Framework Aims to Guide Mantle Cell Lymphoma Therapy

A risk-adapted framework uses diagnostic markers to tailor MCL therapy and guide MRD-informed management. More...
07 Sep 2026
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

WHO granted Emergency Use Listing (EUL) for Cepheid's Xpert Hemorrhagic Fever Panel to support diagnostics during the Ebola Bundibugyo outbreak. More...
07 Sep 2026
Image: The latest FDA approval expands the Guardant360 CDx platform to 29 companion diagnostic indications globally (Photo courtesy of Guardant Health)

FDA Clears Liquid Biopsy Test to Guide Earlier Breast Cancer Therapy Switch

Guardant360 CDx was FDA-approved to identify ESR1 mutations and guide camizestrant use in HR+/HER2- breast cancer. More...
07 Sep 2026
Image Credit: Adobe Stock

New Gene-Disease Link May Help Diagnose Rare Neurodevelopmental Disorders

New data identify gene variants linked to a neurodevelopmental disorder, enabling faster diagnosis and variant interpretation. More...
07 Sep 2026
Image: The latest FDA approval expands the Guardant360 CDx platform to 29 companion diagnostic indications globally (Photo courtesy of Guardant Health)

FDA Clears Liquid Biopsy Test to Guide Earlier Breast Cancer Therapy Switch

Guardant360 CDx was FDA-approved to identify ESR1 mutations and guide camizestrant use in HR+/HER2- breast cancer. More...
05 Sep 2026
Image: Findings show that low circulating ISM2 around 12 weeks gestation was the strongest indicator of later pregnancy complications (Image Credit: Adobe Stock)

New Blood Biomarker Predicts May Predict Preeclampsia and Fetal Growth Restriction

A new biomarker candidate measured in first trimester improves prediction of preeclampsia and fetal growth restriction. More...
04 Sep 2026
Image: PrepQuant integrates nucleic acid extraction, concentration, and quantification into one automated platform. (Photo courtesy of Invivoscribe)

Automated System Streamlines DNA Recovery for MRD-Sensitive Testing

Invivoscribe’s PrepQuant System is now shipping commercially in North America, moving from validation to customer deployment. More...
04 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Electrolyte Analyzer
BKE-B
Immunofluorescence Analyzer
IFA System
Copyright © 2000-2026 Globetech Media. All rights reserved.